Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis
Open Access
- 21 December 2011
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 83 (3) , 282-287
Abstract
Background Evaluating the long term benefit of therapy in multiple sclerosis (MS) is challenging. Although randomised controlled trials (RCTs) demonstrate therapeutic benefits on short term outcomes, the relationship between these outcomes and late disability is not established. Methods In a patient cohort from the pivotal interferon β-1b trial, the value of clinical and MRI measures were analysed, both at baseline and during the RCT, for predicting long term physical and cognitive outcome. Results Baseline disability correlated with both physical (R2=0.22; p2=0.12; p2=0.12; p2=0.12; p2=0.21; pConclusions Although on-trial change in some short term clinical measures correlated with long term physical and disability outcomes, the proportion of the variance explained by single commonly employed on-study variables was often small or undetectable. Better correlations were observed for several baseline measures, suggesting that long term outcome in MS may be largely determined early in the disease course. Trial registration number http://Clinical Trials.gov, study registration NCT00206635.Keywords
This publication has 12 references indexed in Scilit:
- The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disabilityBrain, 2010
- Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: A meta‐analytic approachAnnals of Neurology, 2009
- Cognitive impairment in multiple sclerosis can be predicted by imaging early in the diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Magnetic resonance imaging measures of brain and spinal cord atrophy correlate with clinical impairment in secondary progressive multiple sclerosisMultiple Sclerosis Journal, 2008
- Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MSNeurology, 2006
- Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: Have we been overly harsh in our assessment?Annals of Neurology, 2006
- A perfect correlate does not a surrogate makeBMC Medical Research Methodology, 2003
- Eight-year follow-up study of brain atrophy in patients with MSNeurology, 2002
- Surrogate end points in cardiovascular disease trialsAmerican Heart Journal, 2000
- Axonal pathology in multiple sclerosis: relationship to neurologic disabilityCurrent Opinion in Neurology, 1999